Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Atea Pharmaceuticals, Inc.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Use of adequate contraception for females of childbearing potential
Must be direct-acting antiviral (DAA)-treatment-naïve (never exposed to an approved or experimental DAA for HCV)
Documented medical history compatible with chronic HCV
Either no liver cirrhosis or with compensated liver cirrhosis
If HIV-1-positive, must meet the following 2 criteria:
1. Antiretroviral (ARV) regimen for \>8 weeks prior to screening visit, with CD4 T-cell count \>200 cells/mm3 and plasma HIV-1 RNA \<LLOQ
2. Suitable ARV treatment and not taking any contraindicated medications
You may not be if
Pregnant or breastfeeding
Co-infected with hepatitis B virus
Abuse of alcohol and/or illicit drug use that could interfere with adherence to study requirements as judged by the investigator
Requirement of any prohibited medications
Use of other investigational drugs within 30 days of dosing
History or signs of decompensated liver disease (decompensated cirrhosis)
History of hepatocellular carcinoma (HCC)
Any other clinically significant medical condition that, in the opinion of the investigator, would jeopardize the safety of the subject or impact the validity of the study results
